Cargando…
Prognostic Significance of Deregulated Dicer Expression in Breast Cancer
BACKGROUND: Dicer, an RNase III-type endonuclease, is the key enzyme involved in RNA interference and microRNA pathways. Aberrant expression of Dicer is reported in several human cancers. Our aim was to assess the prognostic role of Dicer in breast cancer. METHODS: The entire series comprised 666 in...
Autores principales: | Caffrey, Emer, Ingoldsby, Helen, Wall, Deirdre, Webber, Mark, Dinneen, Kate, Murillo, Laura S., Inderhaug, Celine, Newell, John, Gupta, Sanjeev, Callagy, Grace |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875475/ https://www.ncbi.nlm.nih.gov/pubmed/24386264 http://dx.doi.org/10.1371/journal.pone.0083724 |
Ejemplares similares
-
Breast carcinoma: molecular markers and subtypes to predict patients at risk of developing metastatic disease
por: Inderhaug, CR, et al.
Publicado: (2009) -
Deregulation of dicer and mir-155 expression in liposarcoma
por: Vincenzi, Bruno, et al.
Publicado: (2015) -
Prognostic significance of Dicer expression in hepatocellular carcinoma
por: ZHANG, LI, et al.
Publicado: (2016) -
Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer
por: Callagy, Grace M, et al.
Publicado: (2008) -
The nuclear DICER–circular RNA complex drives the deregulation of the glioblastoma cell microRNAome
por: Bronisz, A., et al.
Publicado: (2020)